Back Refine search Reset
Please choose a search criteria from below
Filters Clear all
Specialties
Treatments

34 results found for Oncology in London

Sort by:
Showing 1 - 10 of 34 results

Professor Elinor Sawyer is a Consultant Clinical Oncologist with a specialist interest in the treatment of breast cancer. She is based at Guy’s & St Thomas’ Hospital but also performs private work and is Professor in Oncology at King’s College London.

She completed her clinical oncology training at University College London, Royal Free and St Thomas’ Hospitals. Following this, she obtained her PhD in molecular genetics of cancer at the London Research Institute. In 2005 she was appointed as a Consultant Oncologist at Guy’s & St Thomas’ Hospital.


As well as her clinical practice, Professor Sawyer is heavily involved in research and her work has been published in a number of peer reviewed journals. Her main areas of research include genetic predisposition to breast cancer, particularly lobular breast cancer and pre invasive cancer (DCIS and LCIS), and identification of biomarkers that predict progression of early breast cancer.


Diseases, Medical Tests and Treatments
  • Chemotherapy 
  • Immunotherapy 
  • Breast Cancer 
Read more
Oncology
26 years of experience
Prostate Cancer, Clinical Oncology

Dr Stephen Morris is a consultant in Clinical Oncology at Guy's and St Thomas' Hospitals, specialising in the management of skin and urological cancers. He specialises in brachytherapy, external beam radiotherapy and chemotherapy for prostate cancer at Guys Hospital. He also leads the chemotherapy and radiotherapy service for cutaneous lymphoma at the St Johns Institute of dermatology at Guys.

Dr Morris completed his initial medical training at Guy's and St Thomas' medical school. Following this, he trained in clinical oncology at the Royal Marsden Hospital and the Guy's and St Thomas' Cancer Centre. At Guys he was involved in setting up the dynamic prostate brachytherapy service and since his appointment as a consultant, has continued to innovate in the field, working for ever-improving outcomes for patients.

In addition to his work in research and clinical trials, he has led the design and implementation of a new modern Total Skin Electron Beam technique for cutaneous lymphoma, IMRT and IGRT for prostate cancer and more recently has developed and implemented the use of the SpaceOAR and Auto Beam Hold intra fraction IGRT technique for prostate cancer. Dr Morris is also a keen teacher and involved in education as a tutor for clinical oncology.


Diseases, Medical Tests and Treatments
  • Prostate brachytherapy
  • Radiotherapy
  • Chemotherapy
  • Clinical Trials
  • Urological oncology 
  • Dermatological oncology
  • Cutaneous lymphoma and melanoma
  • Prostate cancer

 

Read more
Oncology
31 years of experience
Clinical Oncology

Professor Andrew Tutt is a Consultant Clinical Oncologist specialising in breast cancer. He is based at Guy’s Hospital Breast Unit but also performs private work and is a Professor of Oncology at King’s College London School of Medicine.

He qualified in medicine in 1990 and went on to complete his postgraduate training at a number of hospitals around the UK. After completing his clinical oncology training at the Royal Marsden Hospital London, he was awarded a Doctoral Research Training Fellowship at The Institute of Cancer Research, London, where he gained his PhD in cancer biology.

Professor Tutt is actively involved in clinical research and has published a number of breast cancer research papers. His main areas of research include the ‘triple negative’ and BRCA1 and BRCA2 associated breast cancers. He has led a number of international trials of drug therapies and research programmes in these areas.

He is often asked to speak at major European and North American Cancer Medicine conferences. He is a member of the St Gallen International Breast Cancer Consensus Panel that develops guidelines for the treatment of breast cancer. He is also part of a UK team that trial new techniques in breast radiotherapy.


Diseases, Medical Tests and Treatments
  • Biological Therapy 
  • Chemotherapy 
  • Radiotherapy 
  • Breast Cancer 
Read more

Professor Schmid is an internationally renowned breast cancer oncologist. He is the clinical director of the Breast Cancer Centre at St. Bartholomew’s Hospital in London, and Chair in Cancer Medicine at Barts Cancer Institute, Queen Mary University London.

Professor Peter Schmid’s work is devoted to incorporating novel therapies based on an understanding of the biology of cancer with excellent quality of care into the treatment of women with breast cancer. He has an interest in breast cancer from diagnosis throughout treatment to optimal recovery, and also has a particular interest in triple-negative breast cancer, young women with breast cancer, pregnancy-associated breast cancer, and fertility-related issues. Professor Schmid is committed to patient-centered, holistic care, tailoring treatments for individual patients using biology, personal preference, and constant review of outcomes of care. He works in the context of a multidisciplinary team with breast care nurse support for patients. Professor Schmid has a strong interest in patient-doctor communication and ran a training program for oncologists and oncology nurses for many years. Professor Schmid’s research is dedicated to improving the care of women with breast cancer by developing more effective and less toxic treatments.

It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.

Read more
Oncology
20 years of experience
Bowel Cancer, Clinical Oncology, Colon Cancer + 5more

Dr. Asad Qureshi is a Consultant Clinical Oncologist with many years of experience in the treatment of gastro-intestinal cancer, including oesophageal cancer, stomach cancer, colon cancer, rectal cancer, and anal cancer.

Dr. Qureshi earned his primary medical qualification at St Bartholomew's and The Royal London Hospital Medical School in 1995. Dr Qureshi then went on to undertake his specialist clinical oncology training at various renowned London hospitals Charing Cross Hospital, St Barts Hospital, Guy’s and St Thomas, and the The Royal Marsden. During this time, Dr Qureshi also completed a research degree in imagining sciences at King's College London evaluating novel radiotherapy techniques in the treatment of lung cancer. Upon completion of his training, Dr Qureshi was appointed Consultant at Guy’s and St Thomas Hospital in 2014, where he had a key role in the opening of the new Cancer Centre and has held senior management positions.

Dr Qureshi is also an active member of the scientific research community and has a keen interest in stereotactic and image-guided radiotherapy, for which he has written a number of peer-reviewed research articles. He is currently the principal investigator for various cancer clinical trials and is also an active member of the medical education community, being a clinical supervisor for clinical oncology junior doctors .

Read more
Oncology
Recommended by 1 specialist
33 years of experience
Clinical Oncology

Lucy Brazil is a Consultant Oncologist who has been with Guy’s and St Thomas’ and King’s College Hospitals since 2005. In 2007, she was awarded an MD for research into breast cancer genetics at the Institute of Cancer Research and Breakthrough Breast Cancer.

Dr Brazil trained in oncology at the Royal Marsden Hospital and Guy’s and St Thomas’ Hospitals. Her specialist interests include neuro-oncology particularly high grade glioblastoma multiforme and low grade glioma including oligodendroglioma and spinal tumours and breast cancer including management of brain metastases. Dr Brazil has expertise in radiotherapy both standard conformal and stereotactic techniques and including Cyberknife, Rapid-Arc and IMRT. She also oversees chemotherapy and endocrine treatments.

Dr Brazil is a member of the NCI National Cancer Institute Brain Tumour Clinical Studies Group and the EORTC European Organisation of Research and Treatment of Cancer Brain Tumour Group. She is chief investigator for the CODEL brain tumour study using chemotherapy and radiotherapy for grade 3 gliomas, chairman of the brain-tumour palliative care sub-group and neuro-oncology research lead at Guy's and St Thomas' in addition to being systemic chemotherapy neuro-oncology lead at the hospital.

 


Diseases, Medical Tests and Treatments
  • Radiotherapy
  • Chemotherapy
  • Immunotherapy
  • Palliative Care
  • Brain Cancer
  • Breast Cancer
  • Neuro-oncology
Read more
Oncology
Recommended by 1 specialist
23 years of experience
Breast Cancer, Medical Oncology

Dr Kristeleit completed his undergraduate studies at the Universities of Bonn (Germany), Lausanne (Switzerland) and Barts and The London School of Medicine. He has a first class medical degree from Bonn University and performed his post graduate and specialist training in London teaching hospitals. He spent four years as an AVON Clinical Research Fellow at the Breakthrough Breast Cancer Research Centre investigating novel targets in familial breast cancer. He was appointed as a Consultant Medical Oncologist at Guy's and St Thomas' NHS Foundation Trust in 2009.

He has a special interest in breast cancer and Acute Oncology. He provides the medical oncology service for breast cancer at Queen Elizabeth and Queen Mary's hospitals and is currently the lead clinician for Acute Oncology in the South East London Accountable Cancer Network. Dr Kristeleit has a keen research interest in the role of novel therapies for breast cancer. He is an investigator on numerous clinical trials for breast cancer and chairs the oncology research committee at Guy's and St Thomas'.

He gives regular lectures for the University of London and has been invited to speak at national conferences and international meetings. He specializes in the treatment of early and advanced breast cancer.


Diseases, Medical Tests and Treatments

Read more
Oncology
31 years of experience
Breast Cancer, Medical Oncology, Advanced Melanoma

 

Dr Mark Harries is a Consultant Medical Oncologist at Guy's & St Thomas' Hospitals NHS Foundation Trust and honorary senior lecturer at Kings College London School of Medicine - he also sees patients privately. He specialises in the treatment of breast cancer and melanoma.

Dr Harries graduated from Cambridge University and underwent clinical training at the Royal London Hospital. He then trained in medical oncology at the Royal Marsden Hospital and completed a PhD and post-doctoral work in the Department of Immunology at University College, London. His research interests include immunotherapy for melanoma and breast cancer as well as clinical trials of new biological agents for these diseases.

He has published many papers and presents on a regular basis at national and international conferences. He is the Oncology Editor for the International Journal of Clinical Practice. Dr Harries is also an honorary senior lecturer at King's College London School of Medicine. 

Diseases, Medical Tests and Treatments

  • Chemotherapy
  • Immunotherapy
  • Biological therapy
  • Hormonal therapy
  • Breast Cancer
  • Melanoma

It is important that HCA is transparent about our relationship with those doctors who provide us with clinical guidance on delivering the best possible care to patients and operating our hospitals safely and efficiently. We set out here some of the ways in which we work together and the amount we pay this doctor for such services.

 

Read more

George Mikhaeel is a Professor of Radiation Oncology at King’s College London and Consultant Clinical Oncologist at Guy’s & St Thomas’ NHS Foundation Trust since 2001. He specialises in the treatment of lymphoma with both chemotherapy and radiotherapy and has extensive experience in advanced radiotherapy techniques for haematological malignancies.

Professor Mikhaeel’s research has resulted in new ways of treating lymphoma patients with radiotherapy, harnessing the benefits of advances in radiotherapy technology and advances in imaging. An example of new treatments is combining an innovative arc technique and deep inspiration breath-hold (DIBH) with image-guided delivery of treatment to improve the accuracy of targeting radiation and reduce dose to healthy tissues.

His clinical practice is focused only on haematological malignancies which are less common and require a high level of specialisation and substantial clinical experience, having practised in this field for more 20 years. Professor Mikhaeel has lectured in more than 15 countries and has numerous publications in the field including four influential international guidelines.

He is a founding member of the International Lymphoma Radiation Oncology Group (ILROG) and a member of its steering and executive committees. Professor Mikhaeel also chairs the haematology track for the American Society of Radiation Oncology (ASTRO) annual meeting scientific committee and a reviewer for the European Society of Radiation Oncology (ESTRO). Nationally, he is the chair of the UK Lymphoma Radiotherapy Group (UK-LRG) steering committee.


Diseases, Medical Tests and Treatments


  • Radiotherapy
  • Chemotherapy


  • Haematological malignancies
Read more
Oncology
19 years of experience
Medical Oncology

Deborah Enting is a Consultant Medical Oncologist at Guy's and St Thomas' NHS Foundation Trust and an Honorary Senior Lecturer at King's College London.

She undertook her medical training at the University of Groningen in The Netherlands and trained in Medical Oncology at Guy's and St George's Hospitals. She was a research fellow at the Department of Immunobiology at King's College London and in collaboration with colleagues of the Translational Oncology Urology Research (TOUR) group at KCL she works on tumour immune surveillance and bladder cancer research.

Deborah is a Medical Oncologist specialising in the treatment of Urological Cancers and the systemic treatment (chemotherapy, immunotherapy and targeted therapies) for bladder, prostate, kidney and testicular cancers. She is a national lead on a number of clinical trials including the IRONMAN prostate cancer registry study.

 


Diseases, Medical Tests and Treatments
  • Bladder cancer
  • Prostate cancer
  • Kidney cancer
  • Testicular cancer
  • Bladder cancer
  • Prostate cancer
  • Kidney cancer
  • Testicular cancer
Read more